News

GraniteShares Takes Bold Step with CONI Reverse Split Announcement

GraniteShares Takes Bold Step with CONI Reverse Split Announcement

GraniteShares Initiates Exciting Changes for CONI

NEW YORK — GraniteShares is making headlines with the announcement of a reverse share split for its GraniteShares 2x Short COIN fund. This strategic decision is set to reshape the market outlook for CONI while ensuring that the total market value of the shares remains unchanged.

Key Details of the Reverse Split

The reverse share split will take effect after the market closes on the Payable Date. Here’s how it will unfold:

This is set to occur on the pivotal date of the reverse split:

Fund Overview

The GraniteShares 2x Short COIN Daily ETF is designed to provide investors with leveraged exposure. The details of the split are outlined below:

Fund Name: GraniteShares 2x Short COIN Daily ETF

Ticker: CONI

Reverse Split Ratio: 1 for 20

Approximate Decrease in Total Outstanding Shares: 95%

Alterations to CUSIP Codes

In line with the reverse share split, the Fund’s CUSIP will also see a change:

New CUSIP Details

Current CUSIP: 38747R 728
New CUSIP: 38747R 363

Market Trading Adjustments

Investors should note that the reverse share split will impact shareholders of record by the end of trading on the NASDAQ, and the new split-adjusted shares will begin trading shortly thereafter. The anticipated result is a heightened opening market price for shares held by investors, potentially making it a prudent move for those monitoring their portfolios closely.

Impact of the Split

The reverse split strategy aims to stabilize the share price of the fund, providing an opportunity for renewed investor interest. For example, a hypothetical investment scenario might showcase a pre-split holding of 1,000 shares with an NAV of $1.00 per share, resulting in a total market value of $1,000. After the reverse split, this would convert to 50 shares valued at $20.00 each, maintaining the overall investment value stable.

Rationale Behind the Reverse Split

GraniteShares aims to optimize its market strategy through this consolidation of shares, which can potentially enhance liquidity in trading. The management believes this proactive approach can lead to a healthier trading environment, making shares more accessible for a wider range of investors.

Fractional Shares Redemption

With the reverse split, some investors may find themselves holding fractional shares. However, as these cannot be traded on the NASDAQ, GraniteShares will offer to redeem these fractional shares for cash at the split-adjusted NAV. Investors should consider potential tax implications related to these transactions, while also recognizing that the split itself won't trigger a taxable event for most shareholders.

About GraniteShares

GraniteShares stands out as an independent ETF issuer known for its innovative approach to asset management. The company focuses on providing investors with unique, high-performance investment opportunities through a diverse range of leveraged ETFs.

Conclusion

In conclusion, the reverse split of the GraniteShares 2x Short COIN ETF (CONI) is a strategic maneuver that highlights GraniteShares' commitment to enhancing shareholder value and market positioning. Investors are encouraged to evaluate how this news aligns with their financial strategies as trading and pricing dynamics evolve.

Frequently Asked Questions

What is a reverse share split?

A reverse share split reduces the number of outstanding shares while increasing the price per share, aimed at enhancing overall market attractiveness.

How will this affect current shareholders of CONI?

Shareholders will retain the same overall value of their investment despite having fewer shares after the split.

Will the NAV change due to the reverse split?

The NAV per share will increase proportionately to maintain the total market value unchanged.

What should investors do if they hold fractional shares?

GraniteShares will redeem fractional shares for cash at the adjusted NAV, and investors should be aware of potential tax implications.

How does this reverse split position GraniteShares in the ETF market?

This move demonstrates GraniteShares' proactive stance in managing its ETFs, potentially leading to increased investor confidence and stronger trading performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 222

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading

Top 5 Most Recently Viewed Articles

Alto Neuroscience, Inc. Faces Class Action Lawsuit Risk

Updated Category News Views 181

Class Action Lawsuit Against Alto Neuroscience, Inc. Alto Neuroscience, Inc. (NYSE: ANRO) is currently facing a class action lawsuit filed by a national shareholder rights litigation firm. This lawsuit revolves around allegations of securities fraud, claiming the company made misleading statements regarding the efficacy of its product ALTO-100 in treating major depressive...

Continue Reading
Hyatt and Playa Hotels Explore Strategic Partnership Options

Updated Category News Views 218

Hyatt Engages in Exclusive Discussions with Playa Hotels Hyatt Hotels (NYSE: H) is currently in exclusive negotiations regarding a potential takeover of Playa Hotels & Resorts (NASDAQ: PLYA) N.V. This engagement marks a significant move for both companies as they explore various strategic options for the $1.2 billion resort operator. The announcement has generated...

Continue Reading
LingoAce Celebrated as Top Innovator in Global Education Market

Updated Category News Views 111

LingoAce Celebrated as Top Innovator in Global Education Market Pioneering Tech-driven, Personalized Learning for over 580,000 Learners Worldwide LingoAce, a prominent global EdTech company, has received recognition as a 2025 Forbes China Influential Brand in Education. This honor was presented during the inaugural 2025 Forbes China Educational Industry Summit,...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 138

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
NV5 Global Backs Major Coastal Mapping Initiative in New Zealand

Updated Category News Views 197

NV5 Global Secures $4 Million Coastal Mapping Contract NV5 Global, Inc. (NASDAQ: NVEE), a significant player in the professional engineering field, has recently secured a noteworthy contract with Toit? Te Whenua Land Information New Zealand (LINZ) for a $4 million coastal mapping project. This contract is an important milestone in NV5's effort to expand its international...

Continue Reading